In head and neck cancer, nuclear localisation of APE1 was associated with resistance to chemoradiotherapy and poor outcome (Koukourakis et al, 2001), and in cervical cancer, an inverse relationship between intrinsic radiosensitivity and levels of APE1 has been demonstrated (Herring et al, 1998). This evidence concerns the gene APEX1 and head and neck cancer.